Massimo Loda

53PUBLICATIONS
427CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Gene expression (incl. microarray and other genome-wide approaches)Systems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Oct 16, 2026
The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer.

|Sep 10, 2026
Integrated signatures define mutational processes in prostate cancer.

|Sep 09, 2026
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer.

|Apr 03, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli

|Mar 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Sara Bleve, Francesco Ravera, Silvia Rodrigues

|Nov 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Jia J Li, Alessandro Vasciaveo, Dimitris Karagiannis

Pageof 9

Frequent Collaborators

10 joint publications

Brian Robinson

10 joint publications

Kenneth C Anderson

10 joint publications

Lewis C Cantley

9 joint publications

Luis A Diaz